Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host sialylated glycan receptors are terminal carbohydrate structures, typically N-acetylneuraminic acid (Neu5Ac), found on the surface of glycoproteins and glycolipids of mammalian cells (Varki, A. 2008, Trends in Molecular Medicine). These receptors play a fundamental role in biological processes such as cell-cell recognition, immune response modulation via Siglecs, and stabilization of protein conformations (Crocker, P. R., et al. 2007, Nature Reviews Immunology). In the context of infectious diseases, they serve as the primary attachment points for numerous pathogens, including influenza viruses, parainfluenza viruses, and certain coronaviruses (Skehel, J. J., & Wiley, D. C. 2000, Annual Review of Biochemistry). The specificity of the linkage between sialic acid and the underlying galactose (e.g., alpha 2-3 or alpha 2-6) often determines host range and tissue tropism for respiratory viruses. Therapeutic interventions targeting these receptors include sialidases like DAS181, which enzymatically remove the sialic acid residues to prevent viral entry, and glycomimetics that compete for viral binding sites (Moss, R. B., et al. 2012, Expert Opinion on Investigational Drugs). Because of their ubiquitous nature, targeting these receptors requires careful consideration of potential impacts on normal cellular signaling and immune homeostasis.
Enzymatic cleavage of terminal sialic acid residues from host cell surfaces to prevent viral attachment and entry; competitive inhibition of viral hemagglutinin binding to host glycans.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host sialylated glycan receptors.